Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy

Abstract

Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy

Description

Keywords

Citation

Silva AP, Perdigão M, Espírito Santo M, Advinha AM. Pharmacogenomic Biomarkers as a Source of evidence for Effectiveness and Safety in Alzheimer’s Disease Therapy. In: Abstracts of the 4th Annual Summit of the Comprehensive Health Research Centre (CHRC). Évora, Portugal: Port J Public Health, 42(suppl1); 2024. pp.13.

Endorsement

Review

Supplemented By

Referenced By